Studies have reported that the PI3K/Akt/mTOR pathway activation was associated with enhanced invasive and migratory in NSCLC (Fu et al., 2015; Pérez-Ramírez et al., 2015). The gene discussed is MTOR; the disease is non-small cell lung carcinoma.